Insider Transactions in Q2 2025 at Schrodinger, Inc. (SDGR)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 14
2025
|
Karen Akinsanya President of R&D, Therapeutics |
SELL
Open market or private sale
|
Direct |
16,723
-21.46%
|
$418,075
$25.07 P/Share
|
|
Apr 14
2025
|
Karen Akinsanya President of R&D, Therapeutics |
BUY
Exercise of conversion of derivative security
|
Direct |
16,723
+20.47%
|
$50,169
$3.07 P/Share
|